🇩🇪 Qulipta in Germany

Qulipta (ATOGEPANT) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Aquipta
  • Status: approved

Qulipta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Germany

Frequently asked questions

Is Qulipta approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Qulipta in Germany?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.